Multi-vial research order savings: Buy 3 vials and save 10%. Buy 5 vials and save 15%. Research Peptides only. 🎁 EVERY RETAIL ORDER INCLUDES 1 FREE VIAL 🎁 Free shipping on retail orders $350+. Bulk Pre-Orders excluded.
A non-promotional scientific guide to semaglutide covering GLP-1 receptor biology, peptide engineering, albumin binding, DPP-4 resistance, receptor structural research, analytical characterisation and the distinction between semaglutide and the Ozempic/Wegovy pharmaceutical...
A non-promotional scientific guide to semaglutide covering GLP-1 receptor biology, peptide engineering, albumin binding, DPP-4 resistance, receptor structural research, analytical characterisation and the distinction between semaglutide and the Ozempic/Wegovy pharmaceutical...
A scientific and analytical guide to the KLOW 80mg research blend: GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg and KPV 10mg. Covers component evidence, TB-500 identity nuance, multi-peptide HPLC/LC-MS challenges, COA...
A scientific and analytical guide to the KLOW 80mg research blend: GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg and KPV 10mg. Covers component evidence, TB-500 identity nuance, multi-peptide HPLC/LC-MS challenges, COA...
A scientific guide to KPV (Lys-Pro-Val), the C-terminal tripeptide of alpha-MSH, covering its molecular identity, melanocortin relationship, PepT1 research, inflammatory signalling studies, analytical characterisation and evidence limitations.
A scientific guide to KPV (Lys-Pro-Val), the C-terminal tripeptide of alpha-MSH, covering its molecular identity, melanocortin relationship, PepT1 research, inflammatory signalling studies, analytical characterisation and evidence limitations.
A scientific guide to tesamorelin, covering its 44-residue GHRH-derived structure, N-terminal hexenoyl modification, GHRH-receptor signalling, published human research, EGRIFTA brand-name distinction and analytical verification.
A scientific guide to tesamorelin, covering its 44-residue GHRH-derived structure, N-terminal hexenoyl modification, GHRH-receptor signalling, published human research, EGRIFTA brand-name distinction and analytical verification.
A laboratory-focused guide to the 10mg CJC-1295 No DAC + 10mg Ipamorelin research blend, explaining its 20mg total composition, two distinct receptor pathways, analytical challenges, evidence limits and batch verification.
A laboratory-focused guide to the 10mg CJC-1295 No DAC + 10mg Ipamorelin research blend, explaining its 20mg total composition, two distinct receptor pathways, analytical challenges, evidence limits and batch verification.
A scientific guide to Ipamorelin (NNC-26-0161), covering its pentapeptide structure, growth-hormone-secretagogue receptor pharmacology, human PK/PD research, selectivity, analytical characterisation and evidence limitations.
A scientific guide to Ipamorelin (NNC-26-0161), covering its pentapeptide structure, growth-hormone-secretagogue receptor pharmacology, human PK/PD research, selectivity, analytical characterisation and evidence limitations.
Choosing a selection results in a full page refresh.